• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因子 XIII-A 参与调节人源巨噬细胞的基因表达。

Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages.

机构信息

Department of Biochemistry and Molecular Biology, University of Debrecen, Debrecen, Hungary.

出版信息

Thromb Haemost. 2010 Oct;104(4):709-17. doi: 10.1160/TH09-11-0805. Epub 2010 Jul 20.

DOI:10.1160/TH09-11-0805
PMID:20664907
Abstract

Factor XIII subunit A (FXIII-A) is one of the most overrepresented genes that is expressed during the alternative activation of macrophages. Based on its substrate profile and its cellular localisation, FXIII-A is thought to function as an intracellular/intranuclear transglutaminase. Our aim was to find role for the intracellular FXIII-A by comparing the microarray profiles of alternatively activated monocyte-derived macrophages. Microarray analyses of FXIII-A-deficient patients and healthy controls were evaluated, followed by functional clustering of the differentially expressed genes. After a 48-hour differentiation in the presence of interleukin 4 (IL4), 1,017 probes out of the 24,398 expressed in macrophages from FXIII-A- deficient samples were IL4 sensitive, while only 596 probes were IL4 sensitive in wild-type samples. Of these genes, 307 were induced in both the deficient and the wild-type macrophages. Our results revealed that FXIII-A has important role(s) in mediating gene expression changes in macrophages during alternative activation. Functional clustering of the target genes carried out using Cytoscape/BiNGO and Ingenuity Pathways Analysis programs showed that, in the absence of FXIII-A, the most prominent differences are related to immune functions and to wound response. Our findings suggest that functional impairment of macrophages at the level of gene expression regulation plays a role in the wound healing defects of FXIII-A-deficient patients.

摘要

因子 XIII 亚单位 A(FXIII-A)是在巨噬细胞的替代激活过程中表达最丰富的基因之一。基于其底物谱和细胞定位,FXIII-A 被认为是一种细胞内/核内转谷氨酰胺酶。我们的目的是通过比较替代激活的单核细胞衍生的巨噬细胞的微阵列谱来寻找细胞内 FXIII-A 的作用。评估了 FXIII-A 缺陷患者和健康对照的微阵列分析,然后对差异表达基因进行功能聚类。在白细胞介素 4(IL4)存在下分化 48 小时后,从 FXIII-A 缺陷样本中的巨噬细胞中表达的 24,398 个探针中有 1,017 个对 IL4 敏感,而野生型样本中只有 596 个探针对 IL4 敏感。在这些基因中,有 307 个在缺陷型和野生型巨噬细胞中均被诱导。我们的结果表明,FXIII-A 在巨噬细胞的替代激活过程中对介导基因表达变化具有重要作用。使用 Cytoscape/BiNGO 和 Ingenuity Pathways Analysis 程序对靶基因进行功能聚类显示,在缺乏 FXIII-A 的情况下,最明显的差异与免疫功能和伤口反应有关。我们的发现表明,在基因表达调控水平上巨噬细胞功能障碍在 FXIII-A 缺陷患者的伤口愈合缺陷中起作用。

相似文献

1
Factor XIII-A is involved in the regulation of gene expression in alternatively activated human macrophages.因子 XIII-A 参与调节人源巨噬细胞的基因表达。
Thromb Haemost. 2010 Oct;104(4):709-17. doi: 10.1160/TH09-11-0805. Epub 2010 Jul 20.
2
Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit a antigen and transglutaminase activity.先天性缺乏血浆因子XIII的患者的单核细胞缺乏因子XIII亚基a抗原和转谷氨酰胺酶活性。
Thromb Haemost. 1988 Apr 8;59(2):231-5.
3
Identification of factor XIII-A as a marker of alternative macrophage activation.鉴定凝血因子XIII-A作为替代性巨噬细胞活化的标志物。
Cell Mol Life Sci. 2005 Sep;62(18):2132-9. doi: 10.1007/s00018-005-5242-9.
4
Possible role of factor XIII subunit A in Fcgamma and complement receptor-mediated phagocytosis.凝血因子XIII A亚基在Fcγ和补体受体介导的吞噬作用中的可能作用。
Cell Immunol. 2004 Apr;228(2):81-90. doi: 10.1016/j.cellimm.2004.04.007.
5
Substrates of Factor XIII-A: roles in thrombosis and wound healing.因子 XIII-A 的底物:在血栓形成和伤口愈合中的作用。
Clin Sci (Lond). 2013 Feb;124(3):123-37. doi: 10.1042/CS20120233.
6
Factor XIII: a coagulation factor with multiple plasmatic and cellular functions.凝血因子 XIII:一种具有多种血浆和细胞功能的凝血因子。
Physiol Rev. 2011 Jul;91(3):931-72. doi: 10.1152/physrev.00016.2010.
7
Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency.分子建模预测了因子 XIII A 亚基的结构变化,这是在一名患有严重先天性因子 XIII 缺乏症的新生儿中发现的两种新突变引起的。
Thromb Res. 2012 Sep;130(3):506-10. doi: 10.1016/j.thromres.2012.05.003. Epub 2012 May 25.
8
Male-specific cardiac pathologies in mice lacking either the A or B subunit of factor XIII.缺乏凝血因子XIII A亚基或B亚基的小鼠中的雄性特异性心脏病变
Thromb Haemost. 2008 Feb;99(2):401-8. doi: 10.1160/TH07-10-0599.
9
Factor XIII and inflammatory cells.凝血因子 XIII 与炎症细胞。
Thromb Res. 2012 May;129 Suppl 2:S77-81. doi: 10.1016/j.thromres.2012.02.040. Epub 2012 Mar 15.
10
Molecular mechanisms of mutations in factor XIII A-subunit deficiency: in vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins.因子 XIII A 亚基缺乏症中突变的分子机制:在 COS 细胞中的体外表达证明突变蛋白的细胞内降解。
Thromb Haemost. 1997 Jun;77(6):1068-72.

引用本文的文献

1
TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content.肿瘤坏死因子相关凋亡诱导配体(TRAIL)可促进人类巨噬细胞向促炎性M1表型极化,并且与肿瘤巨噬细胞含量高的癌症患者生存率提高相关。
Front Immunol. 2023 Sep 21;14:1209249. doi: 10.3389/fimmu.2023.1209249. eCollection 2023.
2
Cellular FXIII in Human Macrophage-Derived Foam Cells.人巨噬细胞源性泡沫细胞中的细胞 FXIII。
Int J Mol Sci. 2023 Mar 2;24(5):4802. doi: 10.3390/ijms24054802.
3
Expression of factor XIII originating from synovial fibroblasts and macrophages induced by interleukin-6 signaling.
白细胞介素-6信号诱导的滑膜成纤维细胞和巨噬细胞来源的凝血因子XIII的表达。
Inflamm Regen. 2023 Jan 6;43(1):2. doi: 10.1186/s41232-022-00252-4.
4
Coagulation Factor XIII Val34Leu Polymorphism in the Prediction of Premature Cardiovascular Events-The Results of Two Meta-Analyses.凝血因子 XIII Val34Leu 多态性在预测心血管事件中的应用——两项荟萃分析的结果
J Clin Med. 2022 Jun 15;11(12):3454. doi: 10.3390/jcm11123454.
5
Hemostasis components in cerebral amyloid angiopathy and Alzheimer's disease.脑淀粉样血管病和阿尔茨海默病的止血成分。
Neurol Sci. 2021 Aug;42(8):3177-3188. doi: 10.1007/s10072-021-05327-7. Epub 2021 May 27.
6
Factor XIII-A: An Indispensable "Factor" in Haemostasis and Wound Healing.凝血因子 XIII-A:止血和伤口愈合中不可或缺的“因子”
Int J Mol Sci. 2021 Mar 17;22(6):3055. doi: 10.3390/ijms22063055.
7
Coagulation, inflammation, and CD46 transgene expression in neonatal porcine islet xenotransplantation.新生猪胰岛异种移植中的凝血、炎症和 CD46 转基因表达。
Xenotransplantation. 2021 May;28(3):e12680. doi: 10.1111/xen.12680. Epub 2021 Feb 22.
8
Factor XIII-A in Diseases: Role Beyond Blood Coagulation.凝血因子 XIII-A 在疾病中的作用:超越血液凝固的角色。
Int J Mol Sci. 2021 Feb 1;22(3):1459. doi: 10.3390/ijms22031459.
9
Increased coagulation factor XIII activity but not genetic variants of coagulation factors is associated with myocardial infarction in young patients.凝血因子 XIII 活性增加而非凝血因子的遗传变异与年轻患者的心肌梗死有关。
J Thromb Thrombolysis. 2019 Oct;48(3):519-527. doi: 10.1007/s11239-019-01856-3.
10
Factor XIII Subunit A in the Skin: Applications in Diagnosis and Treatment.皮肤中的因子 XIII 亚单位 A:在诊断和治疗中的应用。
Biomed Res Int. 2017;2017:3571861. doi: 10.1155/2017/3571861. Epub 2017 Aug 15.